News & Views
BioFocus Renews French Research Tax Credit
Aug 26 2010
BioFocus, a leading provider of gene-toclinical candidate drug discovery services, has been notified by the French Ministry of Higher Education and Research, that its CIR accreditation had been renewed. This will
allow eligible French companies to benefit from significant tax relief (Crédit d’Impôt sur la Recherche) on research carried out by BioFocus on their behalf until 2013. The accreditation is an extension of the current
agreement, in place since 2008, covering work at both UK and The Netherlands research facilities.
“The renewal of our CIR accreditation allows our eligible clients the opportunity to receive 30% of their R&D costs in tax credits,” said Richard Gordon, Senior Director, Sales and Marketing. “Clients who have benefited from
this facility over the last three years can continue to do so and access BioFocus’ evolving discovery platform.”
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark